Prehospital transdermal glyceryl trinitrate in patients with presumed acute stroke (MR ASAP): an ambulance-based, multicentre, randomised, open-label, blinded endpoint, phase 3 trial

Hester F. Lingsma | L. Beenen | D. Nieboer | F.‐E. Leeuw | P. Nederkoorn | J. Hofmeijer | M. Visser | A. Lugt | A. Yoo | R. Oostenbrugge | S. Roosendaal | C. Majoie | T. Arts | R. V. Eijk | F. Visseren | O. Berkhemer | P. Fransen | D. Dippel | W. Schonewille | B. Emmer | K. Keizer | D. Gerrits | W. V. Zwam | Y. Roos | A. Versteeg | R. Bokkers | S. Manschot | J. Boomsma | J. Coutinho | P. Koudstaal | H. B. Worp | V. Kwa | Lonneke S. F. Yo | M. Kappelhof | V. Chalos | M. Tolhuisen | I. Miedema | D. Pruissen | S. V. D. Berg | A. Siegers | Jorine A van Vliet | N. LeCouffe | K. Treurniet | J. Martens | Martin Sterrenberg | Wilma Pellikaan | R. Sprengers | P. Halkes | Linda Jacobi | L. Rinkel | Josje Brouwer | G. Nijeholt | R. Berg | N. Ghannouti | T. Raaijmakers | Hendrik Reinink | P. V. Doormaal | Bas Hammer | Michelle Simons | Sabrina Verheesen | Eva Ponjee | I. V. D. Wijngaard | H. Kerkhoff | L. Wolff | E. Zock | A. Pirson | Agnetha A. E. Bruggeman | Menno Krietemeijer | L. Sondag | R. Boomars | G. W. V. Dijk | C. Zwetsloot | Robert-Jan B. Goldhoorn | R. V. Nuland | L. Heiligers | H.F.J.Van Voorst | M. V. D. Sluijs | S. U. Venema | Ben Jansen | Mirjam H. Schipper | Alex van 't Net | Tycho Lok | Klaartje Caminada | L. Cuevas | R. P. V. Eijkelenburg | A. Ahee | Wilma Van Wijngaarden | Petra Geijtenbeek | Wilma Oudshoorn | Frans Steenwinkel | Hamdia Samim | Mark van Zandwijk | L. Vrielink | P. J. Mulder | Aico Gerritsen | Jim Ijzermans | Marjan Kooijman | Oscar Francissen | A. V. Es | A. Meijer | Anouk van den Hoorn | Arnolt-Jan Hoving | R. Graaf | Wouter Hinseveld | Wouter van der Steen | Y. Martens | Miranda Slotboom | A. Bruggeman | J. Brouwer | M. Kooijman | G. W. Dijk

[1]  Hester F. Lingsma,et al.  Safety and efficacy of aspirin, unfractionated heparin, both, or neither during endovascular stroke treatment (MR CLEAN-MED): an open-label, multicentre, randomised controlled trial , 2022, The Lancet.

[2]  L. Beenen,et al.  A Randomized Trial of Intravenous Alteplase before Endovascular Treatment for Stroke. , 2021, The New England journal of medicine.

[3]  C. Anderson,et al.  European Stroke Organisation (ESO) guidelines on blood pressure management in acute ischaemic stroke and intracerebral haemorrhage , 2021, European stroke journal.

[4]  P. Willems,et al.  Ultra-early tranexamic acid after subarachnoid haemorrhage (ULTRA): a randomised controlled trial , 2020, The Lancet.

[5]  P. M. Janssen,et al.  Informed consent procedures for emergency interventional research in patients with traumatic brain injury and ischaemic stroke , 2020, The Lancet Neurology.

[6]  C. Beaulieu,et al.  Nitroglycerin Is Not Associated with Improved Cerebral Perfusion in Acute Ischemic Stroke , 2020, Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques.

[7]  Hester F. Lingsma,et al.  Admission Blood Pressure in Relation to Clinical Outcomes and Successful Reperfusion After Endovascular Stroke Treatment , 2020, Stroke.

[8]  W. Powers,et al.  Guidelines for the Early Management of Patients With Acute Ischemic Stroke: 2019 Update to the 2018 Guidelines for the Early Management of Acute Ischemic Stroke: A Guideline for Healthcare Professionals From the American Heart Association/American Stroke Association. , 2019, Stroke.

[9]  Peter J. Godolphin,et al.  Prehospital Transdermal Glyceryl Trinitrate for Ultra-Acute Intracerebral Hemorrhage , 2019, Stroke.

[10]  F. de Leeuw,et al.  Multicentre Randomised trial of Acute Stroke treatment in the Ambulance with a nitroglycerin Patch (MR ASAP): study protocol for a randomised controlled trial , 2019, Trials.

[11]  Peter J. Godolphin,et al.  Prehospital transdermal glyceryl trinitrate in patients with ultra-acute presumed stroke ( RIGHT-2 ) : an ambulance-based , randomised , sham-controlled , blinded , phase 3 trial , 2019 .

[12]  S. Pocock,et al.  Ambulance-delivered transdermal glyceryl trinitrate versus sham for ultra-acute stroke: Rationale, design and protocol for the Rapid Intervention with Glyceryl trinitrate in Hypertensive stroke Trial-2 (RIGHT-2) trial (ISRCTN26986053) , 2019, International journal of stroke : official journal of the International Stroke Society.

[13]  C. Anderson,et al.  Effect of Treatment Delay, Stroke Type, and Thrombolysis on the Effect of Glyceryl Trinitrate, a Nitric Oxide Donor, on Outcome after Acute Stroke: A Systematic Review and Meta-Analysis of Individual Patient from Randomised Trials , 2016, Stroke research and treatment.

[14]  S. Pocock,et al.  Glyceryl Trinitrate for Acute Intracerebral Hemorrhage: Results From the Efficacy of Nitric Oxide in Stroke (ENOS) Trial, a Subgroup Analysis , 2016, Stroke.

[15]  J. Wardlaw,et al.  Effect of Hyperacute Administration (Within 6 Hours) of Transdermal Glyceryl Trinitrate, a Nitric Oxide Donor, on Outcome After Stroke: Subgroup Analysis of the Efficacy of Nitric Oxide in Stroke (ENOS) Trial , 2015, Stroke.

[16]  A. Demchuk,et al.  The Heidelberg Bleeding Classification: Classification of Bleeding Events After Ischemic Stroke and Reperfusion Therapy. , 2015, Stroke.

[17]  C. Anderson,et al.  Guidelines for the Management of Spontaneous Intracerebral Hemorrhage: A Guideline for Healthcare Professionals From the American Heart Association/American Stroke Association , 2015, Stroke.

[18]  E. T. Investigators,et al.  Efficacy of nitric oxide, with or without continuing antihypertensive treatment, for management of high blood pressure in acute stroke (ENOS): a partial-factorial randomised controlled trial , 2015, The Lancet.

[19]  R. Conwit,et al.  Prehospital use of magnesium sulfate as neuroprotection in acute stroke. , 2015, The New England journal of medicine.

[20]  P. Bath,et al.  Feasibility of an Ambulance-Based Stroke Trial, and Safety of Glyceryl Trinitrate in Ultra-Acute Stroke: The Rapid Intervention With Glyceryl Trinitrate in Hypertensive Stroke Trial (RIGHT, ISRCTN66434824) , 2013, Stroke.

[21]  L. Shaw,et al.  Paramedic Initiated Lisinopril For Acute Stroke Treatment (PIL-FAST): results from the pilot randomised controlled trial , 2013, Emergency Medicine Journal.

[22]  W. Owens.  Blood Pressure Control in Acute Cerebrovascular Disease , 2011, Journal of clinical hypertension.

[23]  J. Wardlaw,et al.  Transdermal Glyceryl Trinitrate Lowers Blood Pressure and Maintains Cerebral Blood Flow in Recent Stroke , 2006, Hypertension.

[24]  P. Bath,et al.  A systematic review of nitric oxide donors and L-arginine in experimental stroke; effects on infarct size and cerebral blood flow. , 2005, Nitric oxide : biology and chemistry.

[25]  Jo Leonardi-Bee,et al.  High Blood Pressure in Acute Stroke and Subsequent Outcome: A Systematic Review , 2004 .

[26]  P. Sandercock,et al.  Blood Pressure and Clinical Outcomes in the International Stroke Trial , 2002, Stroke.

[27]  P. Bath,et al.  The Effect of Transdermal Glyceryl Trinitrate, a Nitric Oxide Donor, on Blood Pressure and Platelet Function in Acute Stroke , 2001, Cerebrovascular Diseases.

[28]  Silvia D. Olabarriaga,et al.  Automated segmentation of subarachnoid hemorrhages with convolutional neural networks , 2020 .

[29]  N. Benjamin,et al.  Inhibition of platelet aggregation with glyceryl trinitrate and xanthine oxidoreductase. , 2000, The Journal of pharmacology and experimental therapeutics.